Cargando…

Major Histocompatibility Complex Class I Molecules Modulate Activation Threshold and Early Signaling of T Cell Antigen Receptor–γ/δ Stimulated by Nonpeptidic Ligands

Killer cell inhibitory receptors and CD94-NKG2-A/B heterodimers are major histocompatibility complex class I–specific inhibitory receptors expressed by natural killer cells, T cell antigen receptor (TCR)-γ/δ cells, and a subset of TCR-α/β cells. We studied the functional interaction between TCR-γ/δ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carena, Ilaria, Shamshiev, Abdijapar, Donda, Alena, Colonna, Marco, Libero, Gennaro De
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1997
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199143/ https://www.ncbi.nlm.nih.gov/pubmed/9362537

Ejemplares similares

Functional Inactivation in the Whole Population of Human Vγ9/Vδ2 T Lymphocytes Induced By a Nonpeptidic Antagonist
por: Bürk, Martin R., et al.
Publicado: (1997)

Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo
por: Haurum, John S., et al.
Publicado: (1999)

Presentation of the Same Glycolipid by Different CD1 Molecules
por: Shamshiev, A., et al.
Publicado: (2002)

Major Histocompatibility Complex Class II Expression by Intrinsic Renal Cells Is Required for Crescentic Glomerulonephritis
por: Li, Shuo, et al.
Publicado: (1998)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity
por: De Laurenzi, Vincenzo, et al.
Publicado: (1998)

Sγ3 switch sequences function in place of endogenous Sγ1 to mediate antibody class switching
por: Zarrin, Ali A., et al.
Publicado: (2008)

Development of Cd8α/α and Cd8α/β T Cells in Major Histocompatibility Complex Class I–Deficient Mice
por: Das, Gobardhan, et al.
Publicado: (1999)

Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction
por: Kurts, Christian, et al.
Publicado: (1998)

Essential and Partially Overlapping Role of CD3γ and CD3δ for Development of αβ and γδ T Lymphocytes
por: Wang, Baoping, et al.
Publicado: (1998)

Selection and Expansion of CD8α/α(1) T Cell Receptor α/β(1) Intestinal Intraepithelial Lymphocytes in the Absence of Both Classical Major Histocompatibility Complex Class I and Nonclassical Cd1 Molecules
por: Park, Se-Ho, et al.
Publicado: (1999)

The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains
por: Machold, Robert P., et al.
Publicado: (1997)

Different composition of the human and the mouse γδ T cell receptor explains different phenotypes of CD3γ and CD3δ immunodeficiencies
por: Siegers, Gabrielle M., et al.
Publicado: (2007)

A Monoclonal Antibody to the α2 Domain of Murine Major Histocompatibility Complex Class I that Specifically Kills Activated Lymphocytes and Blocks Liver Damage in the Concanavalin A Hepatitis Model
por: Matsuoka, Shuji, et al.
Publicado: (2003)

Induction of a Diverse T Cell Receptor γ/δ Repertoire by the Helix-Loop-Helix Proteins E2a and Heb in Nonlymphoid Cells
por: Ghosh, Jimut Kanti, et al.
Publicado: (2001)

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
por: Giorgioni, Gianfabio, et al.
Publicado: (2022)

Coarse-grained modeling study of nonpeptide RGD ligand density and PEG molecular weight on the conformation of poly(γ-glutamyl-glutamate) paclitaxel conjugates
por: Peng, Lili X., et al.
Publicado: (2011)

Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells
por: Moniruzzaman, Md, et al.
Publicado: (2023)

Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity
por: Shamshiev, Abdijapar T., et al.
Publicado: (2007)

Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis
por: Borrego, Francisco, et al.
Publicado: (1998)

Targeting Staphylococcus aureus Quorum Sensing with Nonpeptidic Small Molecule Inhibitors
por: Murray, Ewan J., et al.
Publicado: (2014)

EVIDENCE FOR LINKAGE BETWEEN HL-A HISTOCOMPATIBILITY GENES AND THOSE INVOLVED IN THE SYNTHESIS OF THE SECOND COMPONENT OF COMPLEMENT
por: Fu, S. M., et al.
Publicado: (1974)

A constant affinity threshold for T cell tolerance
por: Naeher, Dieter, et al.
Publicado: (2007)

Deamidation of Asparagine in a Major Histocompatibility Complex–Bound Peptide Affects T Cell Recognition but Does Not Explain Type B Reactivity
por: Cirrito, Thomas P., et al.
Publicado: (2001)

Melanoma Cells Present a MAGE-3 Epitope to CD4(+) Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
por: Manici, Simona, et al.
Publicado: (1999)

The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure
Publicado: (1991)

Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2
por: Bretscher, Peter, et al.
Publicado: (2015)

The Direct Binding of a p58 Killer Cell Inhibitory Receptor to Human Histocompatibility Leukocyte Antigen (HLA)-Cw4 Exhibits Peptide Selectivity
por: Rajagopalan, Sumati, et al.
Publicado: (1997)

A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells
por: Colonna, Marco, et al.
Publicado: (1997)

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson’s Disease
por: Kilpeläinen, Tommi P., et al.
Publicado: (2023)

The Epithelial Cellular Adhesion Molecule (EP-Cam) Is a Ligand for the Leukocyte-Associated Immunoglobulin-like Receptor (Lair)
por: Meyaard, Linde, et al.
Publicado: (2001)

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activation
por: Ghosh, Mallika, et al.
Publicado: (2007)

INTERACTION OF AGGREGATED γ-GLOBULIN WITH B LYMPHOCYTES
por: Dickler, H. B., et al.
Publicado: (1972)

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing
por: Suda, Takashi, et al.
Publicado: (1997)

Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands
por: Paul, Sinu, et al.
Publicado: (2018)

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
por: Jäger, Elke, et al.
Publicado: (1998)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Complementary and Alternative Medicine in Children with Type 1 Diabetes Mellitus
por: Haliloglu, Belma, et al.
Publicado: (2011)

3M Syndrome: A Report of Four Cases in Two Families
por: Güven, Ayla, et al.
Publicado: (2011)

Thermo‐kinetic analysis space expansion for cyclophilin‐ligand interactions – identification of a new nonpeptide inhibitor using Biacore™ T200
por: Wear, Martin A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_to69ebf4bu74v3tcpuacreaq4s